Characterization of a novel mouse monoclonal antibody, clone 1E8.33, highly specific for human procollagen 11A1, a tumor-associated stromal component

International Journal of Oncology

Volumn 40, Issue 5, 2012, Pages 1447-1454

  García Ocaña, Marcos ^a   Vázquez, Fernando ^a   García Pravia, Carmen ^a,b   Fuentes Martínez, Nelson ^b   Menéndez Rodríguez, Primitiva ^b   Fresno Forcelledo, Florentino ^b   Barneo Serra, Luis ^a,b   Del Amo Iribarren, Jokin ^c   Simón Buela, Laureano ^d   De Los Toyos, Juan R ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b Central University Hospital of Asturias (HUCA)   (Spain)

^c Progenika Biopharma SA   (Spain)

^d Oncomatrix SL   (Spain)

Author keywords

Monoclonal antibody; Procollagen 11A1; Tumor stroma

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; PROCOLLAGEN; PROCOLLAGEN 11A1; SERINE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CLONE; COMPLEMENTARITY DETERMINING REGION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MYOFIBROBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STAINING; STROMA;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; COLLAGEN TYPE V; COLLAGEN TYPE XI; CROSS REACTIONS; EPITOPE MAPPING; FEMALE; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MYOFIBROBLASTS; PROCOLLAGEN; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS;

EID: 84860297822     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1360     Document Type: Article

References (45)

1. Kalluri R and Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer 6: 392-401, 2006.
2. Mahadevan D and Von Hoff DD: Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther 6: 1186-1197, 2007. (Pubitemid 46711982)
3. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB and Logsdon CD: Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68: 918-926, 2008. (Pubitemid 351206771)
4. Bachem MG, Zhou S, Buck K, Schneiderhan W and Siech M: Pancreatic stellate cells - role in pancreas cancer. Langenbecks Arch Surg 393: 891-900, 2008.
5. Farrow B, Rowley D, Dang T and Berger DH: Characterization of tumor-derived pancreatic stellate cells. J Surg Res 157: 96-102, 2009.
6. Angeli F, Koumakis G, Chen M-C, Kumar S and Delinassios JG: Role of stromal fibroblasts in cancer: promoting or impeding? Tumor Biol 30: 109-120, 2009.
7. Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, van Heek T, Ashfaq R, Meyer R, Walter K, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M and Hruban RH: Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol 160: 1239-1249, 2002. (Pubitemid 34411628)
8. Binkley CE, Zhang L, Greenson JK, Giordano TJ, Kuick R, Misek D, Hanash S, Logsdon CD and Simeone DM: The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma. Pancreas 29: 254-263, 2004. (Pubitemid 40228270)
9. Korc M: Pancreatic cancer-associated stroma production. Am J Surg 194: S84-S86, 2007.
10. Grzesiak JJ, Ho JC, Moossa AR, and Bouvet M: The integrin-extracellular matrix axis in pancreatic cancer. Pancreas 35: 293-301, 2007. (Pubitemid 350307370)
11. Erkan M, Michalski CW, Rieder S, Reiser-Erkan C, Abiatari I, Kolb A, Giese NA, Esposito I, Friess H and Kleeff J: The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol 6: 1155-1161, 2008.
12. Armstrong T, Packham G, Murphy LB, Bateman AC, Conti JA, Fine DR, Johnson CD, Benyon RC and Iredale JP: Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res 10: 7427-7437, 2004. (Pubitemid 39487732)
13. Znati CA, Rosenstein M, McKee TD, Brown E, Turner D, Bloomer WD, Watkins S, Jain RK and Boucher Y: Irradiation reduces interstitial fluid transport and increases the collagen content in tumors. Clin Cancer Res 9: 5508-5513, 2003. (Pubitemid 37499469)
14. Choi J, Credit K, Henderson K, Deverkadra R, He Z, Wiig H, Vanpelt H and Flessner MF: Intraperitoneal immunotherapy for metastatic ovarian carcinoma: resistance of intratumoral collagen to antibody penetration. Clin Cancer Res 12: 1906-1912, 2006.
15. Shoulders MD and Raines RT: Collagen structure and stability. Annu Rev Biochem 78: 929-958, 2009.
16. Fischer H, Salahshor S, Stenling R, Björk J, Lindmark G, Iselius L, Rubio C and Lindblom A: COL11A1 in FAP polyps and in sporadic colorectal tumors. BMC Cancer 1: 17, http://www.biomedcentral.com/1471-2407/1/17, 2001.
17. Fischer H, Stenling R, Rubio C and Lindblom A: Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis 22: 875-878, 2001. (Pubitemid 32514951)
18. Sok JC, Kuriakose MA, Mahajan VB, Pearlman AN, De Lacure MD and Chen FA: Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis. Arch Otolaryngol Head Neck Surg 129: 760-770, 2003. (Pubitemid 36858965)
19. Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR, Wolf GT, Kuick R, Misek DE, Trask DK and Hanash S: Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130: 295-302, 2004. (Pubitemid 38314227)
20. Luparello C and Sirchia R: Type V collagen regulates the expression of apoptotic and stress response genes by breast cancer cells. J Cell Physiol 202: 411-421, 2005. (Pubitemid 40041311)
21. Barneo L, del Amo J, García-Pravia C, de los Toyos JR, Pérez-Basterrechea M, González-Pinto I, Vazquez L, Miyar A and Simón L: Identification of specific genes by microarrays, validation and use of polyclonal antibodies in pancreatic cancer: preliminary results. In: 41st Congress of the European Society for Surgical Research-ESSR 2006. Bologna, Italy. Brigitte Vollmar (ed.): Medimond, International Proceedings: pp27-35, 2006.
22. Del Amo-Iribarren J: Identificación de marcadores para diagnóstico diferencial y potenciales dianas terapéuticas en adenocarcinoma ductal de páncreas mediante herramientas genómicas. Ph.D. Thesis, Universidad del País Vasco, Spain, 2006.
23. Chong IW, Chang MY, Chang HC, Yu YP, Sheu CC, Tsai JR, Hung JY, Chou SH, Tsai MS, Hwang JJ and Lin SR: Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. Oncol Rep 16: 981-988, 2006.
24. Vecchi M, Nuciforo P, Romagnoli S, Confalonieri S, Pellegrini C, Serio G, Quarto M, Capra M, Roviaro GC, Contessini Avesani E, Corsi C, Coggi G, Di Fiore PP and Bosari S: Gene expression of early and advanced gastric cancer. Oncogene 26: 4284-4294, 2007. (Pubitemid 46975798)
25. Badea L, Herlea V, Dima SO, Dumitrascu T and Popescu I: Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 55: 2016-2027, 2008.
26. Halsted KC, Bowen KB, Bond L, Luman SE, Jorcyk CL, Fyffe WE, Kronz JD and Oxford JT: Collagen alpha1(XI) in normal and malignant breast tissue. Mod Pathol 21: 1246-1254, 2008.
27. Bowen KB, Reimers AP, Luman S, Kronz JD, Fyffe WE and Oxford JT: Immunohistochemical localization of collagen type XI alpha1 and alpha2 chains in human colon tissue. J Histochem Cytochem 56: 275-283, 2008. (Pubitemid 351272999)
28. Fuentes-Martínez N: Colágeno 11: Nuevo marcador en el cáncer de mama. Ph.D. Thesis, Universidad de Oviedo, Spain, 2009.
29. Zhao Y, Zhou T, Li A, Yao H, He F, Wang L and Si J: A potential role of collagens expression in distinguishing between premalignant and malignant lesions in stomach. Anat Rec 292: 692-700, 2009.
30. Erkan M, Weis N, Pan Z, Schwager C, Samkharadze T, Jiang X, Wirkner U, Giese NA, Ansorge W, Debus J, Huber PE, Friess H, Abdollahi A and Kleeff J: Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Mol Cancer 23; 9:88. http://www. molecular-cancer.com/content/9/1/88, 2010.
31. Kim H, Watkinson J, Varadan V and Anastassiou D: Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Med Genomics Nov 3;3:51. http://www.biomedcentral.com/1755-8794/3/51, 2010.
32. Fichard A, Tillet E, Delacoux F, Garrone R and Ruggiero F: Human recombinant alpha1(V) collagen chain. Homotrimeric assembly and subsequent processing. J Biol Chem 272: 30083-30087, 1997. (Pubitemid 27512204)
33. Bonod-Bidaud C, Beraud M, Vaganay E, Delacoux F, Font B, Hulmes DJ and Ruggiero F: Enzymatic cleavage specificity of the proalpha1(V) chain processing analysed by site-directed mutagenesis. Biochem J 405: 299-306, 2007. (Pubitemid 47075165)
34. Fernández-Sánchez A, García-Ocaña M and de los Toyos JR: Mouse monoclonal antibodies to pneumococcal C-polysaccharide backbone show restricted usage of VH-DH-JH gene segments and share the same kappa chain. Immunol Lett 123: 125-131, 2009.
35. Brochet X, Lefranc MP and Giudicelli V: IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 36 (Web Server issue): W503-W508, 2008.
36. Mian IS, Bradwell AR and Olson AJ: Structure, function and properties of antibody binding sites. J Mol Biol 217: 133-151, 1991. (Pubitemid 121003282)
37. Ofran Y, Schlessinger A and Rost B: Automated identification of complementarity determining regions (CDRs) reveals peculiar characteristics of CDRs and B cell epitopes. J Immunol 181: 6230-6235, 2008.
38. Kleman JP, Hartmann DJ, Ramirez F and van der Rest M: The human rhabdomyosarcoma cell line A204 lays down a highly insoluble matrix composed mainly of alpha 1 type-XI and alpha 2 type-V collagen chains. Eur J Biochem 210: 329-335, 1992.
39. McQuillan DJ, Richardson MD and Bateman JF: Matrix deposition by a calcifying human osteogenic sarcoma cell line (SAOS-2). Bone 16: 415-426, 1995.
40. Fernandes RJ, Harkey MA, Weis M, Askew JW and Eyre DR: The post-translational phenotype of collagen synthesized by SAOS-2 osteosarcoma cells. Bone 40: 1343-1351, 2007. (Pubitemid 46550987)
41. An JH, Lee SY, Jeon JY, Cho KG, Kim SU and Lee MA: Identification of gliotropic factors that induce human stem cell migration to malignant tumor. J Proteome Res 8: 2873-2881, 2009.
42. Fathallah-Shaykh HM: Logical networks inferred from highly specific discovery of transcriptionally regulated genes predict protein states in cultured gliomas. Biochem Biophys Res Commun 336: 1278-1284, 2005.
43. Böiers U, Lanig H, Sehnert B, Holmdahl R and Burkhardt H: Collagen type II is recognized by a pathogenic antibody through germline encoded structures. Eur J Immunol 38: 2784-2795, 2008.
44. Davies GB, Oxford JT, Hausafus LC, Smoody BF and Morris NP: Temporal and spatial expression of alternative splice-forms of the alpha1(XI) collagen gene in fetal rat cartilage. Dev Dyn 213: 12-26, 1998. (Pubitemid 28394904)
45. Morris NP, Oxford JT, Davies GB, Smoody BF and Keene DR: Developmentally regulated alternative splicing of the alpha1(XI) collagen chain: spatial and temporal segregation of isoforms in the cartilage of fetal rat long bones. J Histochem Cytochem 48: 725-741, 2000. (Pubitemid 30366607)